Cargando…

Combined melatonin and poricoic acid A inhibits renal fibrosis through modulating the interaction of Smad3 and β-catenin pathway in AKI-to-CKD continuum

BACKGROUND: Acute kidney injury (AKI) is one of the major risk factors for progression to chronic kidney disease (CKD) and renal fibrosis. However, effective therapies remain poorly understood. Here, we examined the renoprotective effects of melatonin and poricoic acid A (PAA) isolated from the surf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Dan-Qian, Cao, Gang, Zhao, Hui, Chen, Lin, Yang, Tian, Wang, Ming, Vaziri, Nosratola D., Guo, Yan, Zhao, Ying-Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696851/ https://www.ncbi.nlm.nih.gov/pubmed/31452866 http://dx.doi.org/10.1177/2040622319869116

Ejemplares similares

Poricoic acid A as a modulator of TPH-1 expression inhibits renal fibrosis via modulating protein stability of β-catenin and β-catenin-mediated transcription
por: Chen, Dan-Qian, et al.
Publicado: (2020)

Poricoic acid A suppresses TGF-β1-induced renal fibrosis and proliferation via the PDGF-C, Smad3 and MAPK pathways
por: Li, Qiang, et al.
Publicado: (2021)

Poricoic acid A suppresses renal fibroblast activation and interstitial fibrosis in UUO rats via upregulating Sirt3 and promoting β-catenin K49 deacetylation
por: Chen, Dan-Qian, et al.
Publicado: (2022)

Poricoic Acid A Inhibits the NF-κB/MAPK Pathway to Alleviate Renal Fibrosis in Rats with Cardiorenal Syndrome
por: Chen, Wenzhong, et al.
Publicado: (2022)

Depletion of macrophages with clodronate liposomes partially attenuates renal fibrosis on AKI–CKD transition
por: Hu, Zhizhi, et al.
Publicado: (2023)

Retracted: Poricoic Acid A Inhibits the NF-κB/MAPK Pathway to Alleviate Renal Fibrosis in Rats with Cardiorenal Syndrome
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Infectious consequences of the AKI-to-CKD transition
por: Sánchez Horrillo, Ana, et al.
Publicado: (2022)

TGF‐β/Smad and Wnt/β‐catenin signaling pathways are involved in renal fibrosis and its therapies
por: Ying, Jialiang, et al.
Publicado: (2020)

Dynamic signature of lymphangiogenesis during AKI and CKD
por: Zarjou, Abolfazl, et al.
Publicado: (2019)

The potential roles of galectin-3 in AKI and CKD
por: Wang, Fengyun, et al.
Publicado: (2023)

The AKI-to-CKD Transition: The Role of Uremic Toxins
por: André, Camille, et al.
Publicado: (2023)

REST contributes to AKI-to-CKD transition through inducing ferroptosis in renal tubular epithelial cells
por: Gong, Shuiqin, et al.
Publicado: (2023)

Meta-analysis of AKI to CKD transition in perioperative patients
por: M. Abdala, Pedro, et al.
Publicado: (2021)

Epigenetic memory contributing to the pathogenesis of AKI-to-CKD transition
por: Tanemoto, Fumiaki, et al.
Publicado: (2022)

From AKI to CKD: Maladaptive Repair and the Underlying Mechanisms
por: Wang, Zhiwen, et al.
Publicado: (2022)

RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD
por: Chen, Hui, et al.
Publicado: (2018)

Flavin containing monooxygenase 2 regulates renal tubular cell fibrosis and paracrine secretion via SMURF2 in AKI-CKD transformation
por: Wang, Longfei, et al.
Publicado: (2023)

HDAC3 aberration-incurred GPX4 suppression drives renal ferroptosis and AKI-CKD progression
por: Zhang, Lijun, et al.
Publicado: (2023)

The COVID-19 nephrology compendium: AKI, CKD, ESKD and transplantation
por: Kant, Sam, et al.
Publicado: (2020)

IL-18 deficiency ameliorates the progression from AKI to CKD
por: Luan, Junjun, et al.
Publicado: (2022)

Alisol B 23-acetate attenuates CKD progression by regulating the renin–angiotensin system and gut–kidney axis
por: Chen, Hua, et al.
Publicado: (2020)

Uremic Toxins and Protein-Bound Therapeutics in AKI and CKD: Up-to-Date Evidence
por: Chen, Jia-Huang, et al.
Publicado: (2021)

Activation of EP4 alleviates AKI-to-CKD transition through inducing CPT2-mediated lipophagy in renal macrophages
por: Guan, Xu, et al.
Publicado: (2022)

Irisin Ameliorates Renal Tubulointerstitial Fibrosis by Regulating the Smad4/β-Catenin Pathway in Diabetic Mice
por: Yang, Zhaohua, et al.
Publicado: (2023)

Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease
por: Chen, Dan-Qian, et al.
Publicado: (2017)

Polyporus Umbellatus Protects Against Renal Fibrosis by Regulating Intrarenal Fatty Acyl Metabolites
por: Wang, Yan-Ni, et al.
Publicado: (2021)

EGFR drives the progression of AKI to CKD through HIPK2 overexpression
por: Xu, Luyang, et al.
Publicado: (2019)

The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis
por: Guo, Runzhi, et al.
Publicado: (2023)

Comparison of the treatment efficacy of umbilical mesenchymal stem cell transplantation via renal subcapsular and parenchymal routes in AKI-CKD mice
por: Huang, Mengjie, et al.
Publicado: (2022)

Selective Wnt/β-Catenin Pathway Activation Concomitant With Sustained Overexpression of miR-21 is Responsible for Aristolochic Acid-Induced AKI-to-CKD Transition
por: Kuang, Qing, et al.
Publicado: (2021)

Recombinant Long-Acting Thioredoxin Ameliorates AKI to CKD Transition via Modulating Renal Oxidative Stress and Inflammation
por: Nishida, Kento, et al.
Publicado: (2021)

TGF-β/Smad signaling in renal fibrosis
por: Meng, Xiao-Ming, et al.
Publicado: (2015)

The critical role of FXR is associated with the regulation of autophagy and apoptosis in the progression of AKI to CKD
por: Kim, Dong-Hyun, et al.
Publicado: (2021)

Latent AKI is… still AKI: the quantification of the burden of renal dysfunction
por: Ricci, Zaccaria, et al.
Publicado: (2016)

Poricoic acid A induces apoptosis and autophagy in ovarian cancer via modulating the mTOR/p70s6k signaling axis
por: Ma, Rui, et al.
Publicado: (2021)

Tubular Elabela-APJ axis attenuates ischemia-reperfusion induced acute kidney injury and the following AKI-CKD transition by protecting renal microcirculation
por: Xiong, Mingrui, et al.
Publicado: (2023)

Experimental Aristolochic Acid Nephropathy: A Relevant Model to Study AKI-to-CKD Transition
por: Baudoux, Thomas, et al.
Publicado: (2022)

AKI-to-CKD transition is a potential mechanism for non-albuminuric diabetic kidney disease
por: Lee, Kyung, et al.
Publicado: (2022)

A potential link between fibroblast growth factor-23 and the progression of AKI to CKD
por: Lu, Yinghui, et al.
Publicado: (2023)

Altered gut microbiome plays an important role in AKI to CKD transition in aged mice
por: Kim, Myung-Gyu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kfhj74rdffbo93c14n5ks21nlc